ES1277194Y - Sistema basado en inteligencia artificial para analizar biomarcadores y personalizar tratamientos para cáncer - Google Patents

Sistema basado en inteligencia artificial para analizar biomarcadores y personalizar tratamientos para cáncer

Info

Publication number
ES1277194Y
ES1277194Y ES202130615U ES202130615U ES1277194Y ES 1277194 Y ES1277194 Y ES 1277194Y ES 202130615 U ES202130615 U ES 202130615U ES 202130615 U ES202130615 U ES 202130615U ES 1277194 Y ES1277194 Y ES 1277194Y
Authority
ES
Spain
Prior art keywords
artificial intelligence
based system
cancer treatments
personalize
analyze biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES202130615U
Other languages
English (en)
Other versions
ES1277194U (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keyzell Holding Sl
Original Assignee
Keyzell Holding Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keyzell Holding Sl filed Critical Keyzell Holding Sl
Priority to ES202130615U priority Critical patent/ES1277194Y/es
Publication of ES1277194U publication Critical patent/ES1277194U/es
Application granted granted Critical
Publication of ES1277194Y publication Critical patent/ES1277194Y/es
Priority to EP22174859.3A priority patent/EP4064294A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/045—Combinations of networks
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Data Mining & Analysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Computing Systems (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Artificial Intelligence (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Computational Linguistics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES202130615U 2021-03-25 2021-03-25 Sistema basado en inteligencia artificial para analizar biomarcadores y personalizar tratamientos para cáncer Active ES1277194Y (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES202130615U ES1277194Y (es) 2021-03-25 2021-03-25 Sistema basado en inteligencia artificial para analizar biomarcadores y personalizar tratamientos para cáncer
EP22174859.3A EP4064294A1 (en) 2021-03-25 2022-05-23 Artificial intelligence-based system for analysing biomarkers and personalising cancer treatments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES202130615U ES1277194Y (es) 2021-03-25 2021-03-25 Sistema basado en inteligencia artificial para analizar biomarcadores y personalizar tratamientos para cáncer

Publications (2)

Publication Number Publication Date
ES1277194U ES1277194U (es) 2021-09-03
ES1277194Y true ES1277194Y (es) 2021-11-26

Family

ID=77515541

Family Applications (1)

Application Number Title Priority Date Filing Date
ES202130615U Active ES1277194Y (es) 2021-03-25 2021-03-25 Sistema basado en inteligencia artificial para analizar biomarcadores y personalizar tratamientos para cáncer

Country Status (2)

Country Link
EP (1) EP4064294A1 (es)
ES (1) ES1277194Y (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115691813A (zh) * 2022-12-30 2023-02-03 神州医疗科技股份有限公司 基于基因组学和微生物组学的遗传性胃癌评估方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2279417B1 (en) * 2008-05-28 2016-07-20 Georgia Tech Research Corporation Metabolic biomarkers for ovarian cancer and methods of use thereof
EP2598659B1 (en) 2010-07-27 2015-03-11 Genomic Health, Inc. Method for using gene expression to determine prognosis of prostate cancer
EP2680003A1 (en) 2012-06-28 2014-01-01 Fundació Institut d'Investigació Biomèdica de Bellvitge Serum biomarker for diagnosing colorectal cancer
AU2020274091A1 (en) * 2019-05-14 2021-12-09 Tempus Ai, Inc. Systems and methods for multi-label cancer classification

Also Published As

Publication number Publication date
EP4064294A1 (en) 2022-09-28
ES1277194U (es) 2021-09-03

Similar Documents

Publication Publication Date Title
CL2019000061A1 (es) Anticuerpo para anti-claudin 18a2 y su utilización.
CO2019014414A2 (es) Moléculas de anticuerpo que se unen a cd73 y usos de las mismas
AR114002A1 (es) Anticuerpos a lilrb2
CY1123940T1 (el) Διπλα-ειδικα μονοδυναμα διασωματα που ειναι ικανα συνδεσης cd123 kai cd3, kai χρησεις αυτων
CY1122981T1 (el) Συνθεσεις για διαμορφωση της εκφρασης του c9orf72
BR112017018954A2 (pt) uso de forma mutante de proteína ras e método para tratar câncer
EA201591674A1 (ru) Противораковые вакцины и способы лечения с их применением
BR112018003269A2 (pt) conjugados de fármaco-anticorpo anti-dll3 e métodos de utilização
CL2015001929A1 (es) Sistema y método optico para seleccionar semillas
FI20136314A (fi) Jäätä murtava alus ja menetelmä jäätä murtavan aluksen käyttämiseksi
AR089937A1 (es) Sistema y metodo para la fabricacion descentralizada de neumaticos que permiten caracteristicas mejoradas de desempeño
BR112019005139A2 (pt) anticorpos anti-il-33 e usos dos mesmos
PE20151893A1 (es) Tratamiento del cancer usando anticuerpos que se unen a grp78 en la superficie celular
CL2015003049A1 (es) Variantes de pertuzumab y su evaluación
CL2021003039A1 (es) Moléculas de unión a tigit y pd-1/tigit
DK3262240T3 (da) Vindenergianlægsfundament og vindenergianlæg
CY1121427T1 (el) Χρηση ενος μοριου mir172 για τη μειωση της φλεγμονhς
DK3417058T3 (da) Sortase-modificerede molekyler og anvendelser deraf
ES1277194Y (es) Sistema basado en inteligencia artificial para analizar biomarcadores y personalizar tratamientos para cáncer
CU20160042A7 (es) Anticuerpos conjugados contra antígeno linfocitario 75 para el tratamiento del cáncer
IT201900002557A1 (it) Metodo e sistema di codifica basati su immagini
MA51666A (fr) Variants polypeptidiques et leurs utilisations
BR112016005167A2 (pt) Decodificador de áudio, codificador de áudio e método para alinhamento no tempo de dados de processamento baseados em qmf
CO2022015185A2 (es) Tratamientos con radiación ultravioleta
DK3448149T3 (da) Organkonserverings- og/eller perfusionsopløsninger

Legal Events

Date Code Title Description
CA1K Utility model application published

Ref document number: 1277194

Country of ref document: ES

Kind code of ref document: U

Effective date: 20210903

FG1K Utility model granted

Ref document number: 1277194

Country of ref document: ES

Kind code of ref document: Y

Effective date: 20211122